LEXARIA BIOSCIENCE CORP.— Sankey Diagram
Quarterly mode · period ending 2026-02-28 · SEC EDGAR
ComparingFY2026 (Q4) vs FY2025 (Q4)
Revenue
$20K
↓-88.5% -$154Kvs FY2025 (Q4)
Gross Profit
$20K
↓-88.5% -$154Kvs FY2025 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 (Q4) | FY2025 (Q4) |
|---|---|---|
| Revenue | $20K | $174K |
| COGS | $0 | $0 |
| Gross Profit | $20K | $174K |
| R&D | $475K | $2M |
| SG&A | $0 | $0 |
| D&A | $14K | $2K |
| Other OpEx | $0 | $0 |
| Operating Income | $0 | $0 |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · LEXX · Comparing FY2026 (Q4) vs FY2025 (Q4)